{"transactions":[{"id":2095189,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":121844,"kind":"person","name":"Singer Nicholas Jason","position":1,"cik":"0001828224","reported_name":"Singer Nicholas Jason","relationship":{"director":true}}],"security":"Warrants (right to buy)","published_at":"2022-12-06T23:52:09.000Z","date":"2022-12-02","kind":"purchase","acquired":true,"shares":424928,"price":0.125,"value":53116.0,"ownership":{"direct":false,"nature":"By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 283,286 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share (\"Common Stock\"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 283,286 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share (\"Common Stock\"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules."}],"balance_after":424928,"derivative":{"exercise_price":3.28,"exercise_date":"2023-06-02","expiration_date":"2028-06-02","underlying":"Common Stock, par value $0.005 per share","underlying_shares":424928},"source":{"system":"sec-edgar","filing":"0001140361-22-044631","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122044631/form4.xml","form_type":"4"}},{"id":2095188,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":121844,"kind":"person","name":"Singer Nicholas Jason","position":1,"cik":"0001828224","reported_name":"Singer Nicholas Jason","relationship":{"director":true}}],"security":"Warrants (right to buy)","published_at":"2022-12-06T23:52:09.000Z","date":"2022-12-02","kind":"purchase","acquired":true,"shares":141644,"price":0.125,"value":17705.5,"ownership":{"direct":false,"nature":"By Purchase Capital LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 283,286 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share (\"Common Stock\"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 283,286 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share (\"Common Stock\"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules."}],"balance_after":141644,"derivative":{"exercise_price":3.28,"exercise_date":"2023-06-02","expiration_date":"2028-06-02","underlying":"Common Stock, par value $0.005 per share","underlying_shares":141644},"source":{"system":"sec-edgar","filing":"0001140361-22-044631","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122044631/form4.xml","form_type":"4"}},{"id":2095187,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":121844,"kind":"person","name":"Singer Nicholas Jason","position":1,"cik":"0001828224","reported_name":"Singer Nicholas Jason","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-12-06T23:52:09.000Z","date":"2022-12-02","kind":"purchase","acquired":true,"shares":212464,"price":3.28,"value":696881.92,"ownership":{"direct":false,"nature":"By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 283,286 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share (\"Common Stock\"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules."}],"balance_after":266214,"source":{"system":"sec-edgar","filing":"0001140361-22-044631","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122044631/form4.xml","form_type":"4"}},{"id":2095186,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":121844,"kind":"person","name":"Singer Nicholas Jason","position":1,"cik":"0001828224","reported_name":"Singer Nicholas Jason","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-12-06T23:52:09.000Z","date":"2022-12-02","kind":"purchase","acquired":true,"shares":70822,"price":3.28,"value":232296.16,"ownership":{"direct":false,"nature":"By Purchase Capital LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 283,286 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share (\"Common Stock\"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules."}],"balance_after":121822,"source":{"system":"sec-edgar","filing":"0001140361-22-044631","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122044631/form4.xml","form_type":"4"}},{"id":2196763,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":121844,"kind":"person","name":"Singer Nicholas Jason","position":1,"cik":"0001828224","reported_name":"Singer Nicholas Jason","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-08-04T00:01:21.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":165800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable over two years (subject to continued service), with 1/3 of the shares vesting on the grant date and the remaining shares vesting in 24 substantially equal monthly installments thereafter."}],"balance_after":165800,"derivative":{"exercise_price":0.49,"expiration_date":"2032-08-01","underlying":"Common Stock, par value $0.005 per share","underlying_shares":165800},"source":{"system":"sec-edgar","filing":"0001140361-22-028093","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122028093/form4.xml","form_type":"4"}},{"id":2196762,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":121844,"kind":"person","name":"Singer Nicholas Jason","position":1,"cik":"0001828224","reported_name":"Singer Nicholas Jason","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-08-04T00:01:21.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":146100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable over one year (subject to continued service), with 25% of the shares vesting every three months from the grant date."}],"balance_after":146100,"derivative":{"exercise_price":0.49,"expiration_date":"2032-08-01","underlying":"Common Stock, par value $0.005 per share","underlying_shares":146100},"source":{"system":"sec-edgar","filing":"0001140361-22-028093","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122028093/form4.xml","form_type":"4"}},{"id":2261238,"issuer":{"id":127064,"kind":"organization","name":"OTR Acquisition Corp.","symbol":"OTRA"},"owners":[{"id":121844,"kind":"person","name":"Singer Nicholas Jason","position":1,"cik":"0001828224","reported_name":"Singer Nicholas Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants","published_at":"2022-05-20T16:35:08.000Z","date":"2022-05-20","kind":"other","acquired":false,"shares":762634,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"PC SPAC Holdings LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"In connection with the Business Combination closing, the reporting person exchanged each of its warrants to purchase the issuer's Class A Common Stock on a one for one basis for an aggregate of 762,634 warrants to purchase shares of Holdco's common stock, par value U.S. $0.0001 per share (\"Holdco Common Stock\"), at a purchase price of $11.50 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The warrants were not exercisable until 30 days after the issuer's initial business combination and would have expired five years from the consummation of the issuer's initial business combination."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The warrants were not exercisable until 30 days after the issuer's initial business combination and would have expired five years from the consummation of the issuer's initial business combination."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":762634},"source":{"system":"sec-edgar","filing":"0001104659-22-063406","document":"tm2215573-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1821318/000110465922063406/tm2215573-2_4seq1.xml","form_type":"4"}},{"id":2261237,"issuer":{"id":127064,"kind":"organization","name":"OTR Acquisition Corp.","symbol":"OTRA"},"owners":[{"id":121844,"kind":"person","name":"Singer Nicholas Jason","position":1,"cik":"0001828224","reported_name":"Singer Nicholas Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2022-05-20T16:35:08.000Z","date":"2022-05-20","kind":"exercise","acquired":false,"shares":421759,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"PC SPAC Holdings LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the OTR Acquisition Corp.'s registration statement on Form S-1 (File No. 333-248093) under the heading \"Description of Securities,\" the Class B common stock, par value U.S. $0.0001 per share, of the issuer (the \"Founder Shares\") automatically convert into Class A common stock of the issuer (\"Class A Common Stock\") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 20, 2022, the issuer consummated its initial business combination (the \"Business Combination\") with Comera Life Sciences Holdings, Inc.. (\"Holdco\"), a Delaware corporation. In connection with the Business Combination, each Founder Share converted into Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the OTR Acquisition Corp.'s registration statement on Form S-1 (File No. 333-248093) under the heading \"Description of Securities,\" the Class B common stock, par value U.S. $0.0001 per share, of the issuer (the \"Founder Shares\") automatically convert into Class A common stock of the issuer (\"Class A Common Stock\") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 20, 2022, the issuer consummated its initial business combination (the \"Business Combination\") with Comera Life Sciences Holdings, Inc.. (\"Holdco\"), a Delaware corporation. In connection with the Business Combination, each Founder Share converted into Class A Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the OTR Acquisition Corp.'s registration statement on Form S-1 (File No. 333-248093) under the heading \"Description of Securities,\" the Class B common stock, par value U.S. $0.0001 per share, of the issuer (the \"Founder Shares\") automatically convert into Class A common stock of the issuer (\"Class A Common Stock\") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 20, 2022, the issuer consummated its initial business combination (the \"Business Combination\") with Comera Life Sciences Holdings, Inc.. (\"Holdco\"), a Delaware corporation. In connection with the Business Combination, each Founder Share converted into Class A Common Stock."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":421759},"source":{"system":"sec-edgar","filing":"0001104659-22-063406","document":"tm2215573-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1821318/000110465922063406/tm2215573-2_4seq1.xml","form_type":"4"}},{"id":2261236,"issuer":{"id":127064,"kind":"organization","name":"OTR Acquisition Corp.","symbol":"OTRA"},"owners":[{"id":121844,"kind":"person","name":"Singer Nicholas Jason","position":1,"cik":"0001828224","reported_name":"Singer Nicholas Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2022-05-20T16:35:08.000Z","date":"2022-05-20","kind":"other","acquired":false,"shares":1305918,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the OTR Acquisition Corp.'s registration statement on Form S-1 (File No. 333-248093) under the heading \"Description of Securities,\" the Class B common stock, par value U.S. $0.0001 per share, of the issuer (the \"Founder Shares\") automatically convert into Class A common stock of the issuer (\"Class A Common Stock\") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On May 19, 2022, OTR Acquisition Sponsor LLC (the \"Sponsor\") entered into a certain second amended and restated limited liability operating agreement (the \"Amended LLC Agreement\"). Prior to the Amended LLC Agreement, PC SPAC Holdings LLC, an entity controlled by the reporting person, was the sole managing member of the Sponsor. The Amended LLC Agreement provides that the Sponsor be managed by a board of managers consisting of three persons, including the reporting person. For the purposes of Rule 16a-(1), the reporting person is no longer a beneficial owner of the 1,305,918 shares of Class B common stock, par value U.S. $0.0001 per share, of OTR Acquisition Corp. held directly by the Sponsor, and disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the OTR Acquisition Corp.'s registration statement on Form S-1 (File No. 333-248093) under the heading \"Description of Securities,\" the Class B common stock, par value U.S. $0.0001 per share, of the issuer (the \"Founder Shares\") automatically convert into Class A common stock of the issuer (\"Class A Common Stock\") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the OTR Acquisition Corp.'s registration statement on Form S-1 (File No. 333-248093) under the heading \"Description of Securities,\" the Class B common stock, par value U.S. $0.0001 per share, of the issuer (the \"Founder Shares\") automatically convert into Class A common stock of the issuer (\"Class A Common Stock\") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held indirectly by Nicholas J. Singer, who has sole voting and dispositive control of PC SPAC Holdings LLC."}],"balance_after":421759,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1305918},"source":{"system":"sec-edgar","filing":"0001104659-22-063406","document":"tm2215573-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821318/000110465922063406/tm2215573-2_4seq1.xml","form_type":"4"}},{"id":2261235,"issuer":{"id":127064,"kind":"organization","name":"OTR Acquisition Corp.","symbol":"OTRA"},"owners":[{"id":121844,"kind":"person","name":"Singer Nicholas Jason","position":1,"cik":"0001828224","reported_name":"Singer Nicholas Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-20T16:35:08.000Z","date":"2022-05-20","kind":"other","acquired":false,"shares":421759,"ownership":{"direct":false,"nature":"PC SPAC Holdings LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"In connection with the Business Combination closing, the reporting person exchanged each its shares of Class A Common Stock for 421,759 fully paid and non-assessable shares of Holdco Common Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-063406","document":"tm2215573-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821318/000110465922063406/tm2215573-2_4seq1.xml","form_type":"4"}},{"id":2261234,"issuer":{"id":127064,"kind":"organization","name":"OTR Acquisition Corp.","symbol":"OTRA"},"owners":[{"id":121844,"kind":"person","name":"Singer Nicholas Jason","position":1,"cik":"0001828224","reported_name":"Singer Nicholas Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-20T16:35:08.000Z","date":"2022-05-20","kind":"exercise","acquired":true,"shares":421759,"ownership":{"direct":false,"nature":"PC SPAC Holdings LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As described in the OTR Acquisition Corp.'s registration statement on Form S-1 (File No. 333-248093) under the heading \"Description of Securities,\" the Class B common stock, par value U.S. $0.0001 per share, of the issuer (the \"Founder Shares\") automatically convert into Class A common stock of the issuer (\"Class A Common Stock\") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On May 20, 2022, the issuer consummated its initial business combination (the \"Business Combination\") with Comera Life Sciences Holdings, Inc.. (\"Holdco\"), a Delaware corporation. In connection with the Business Combination, each Founder Share converted into Class A Common Stock."}],"balance_after":421759,"source":{"system":"sec-edgar","filing":"0001104659-22-063406","document":"tm2215573-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821318/000110465922063406/tm2215573-2_4seq1.xml","form_type":"4"}},{"id":2275757,"issuer":{"id":127064,"kind":"organization","name":"OTR Acquisition Corp.","symbol":"OTRA"},"owners":[{"id":121844,"kind":"person","name":"Singer Nicholas Jason","position":1,"cik":"0001828224","reported_name":"Singer Nicholas Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants","published_at":"2022-05-10T08:52:13.000Z","date":"2022-05-06","kind":"other","acquired":false,"shares":5055123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On May 6, 2022, OTR Acquisition Sponsor LLC (the \"Sponsor\") transferred an aggregate of 1,305,920 shares of Class B common stock, par value U.S. $0.0001 per share, of OTR Acquisition Corp. (\"Founder Shares\") and 5,817,757 warrants previously held by the Sponsor to certain members of the Sponsor, including 421,759 Founder Shares and 762,634 warrants to the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The warrants are not exercisable until 30 days after the issuer's initial business combination and expire five years from the consummation of the issuer's initial business combination."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The warrants are not exercisable until 30 days after the issuer's initial business combination and expire five years from the consummation of the issuer's initial business combination."}],"balance_after":762634,"derivative":{"exercise_price":11.5,"underlying":"Class A Common Stock","underlying_shares":5055123},"source":{"system":"sec-edgar","filing":"0001104659-22-057990","document":"tm2214998-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821318/000110465922057990/tm2214998-2_4seq1.xml","form_type":"4"}},{"id":2275756,"issuer":{"id":127064,"kind":"organization","name":"OTR Acquisition Corp.","symbol":"OTRA"},"owners":[{"id":121844,"kind":"person","name":"Singer Nicholas Jason","position":1,"cik":"0001828224","reported_name":"Singer Nicholas Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2022-05-10T08:52:13.000Z","date":"2022-05-06","kind":"other","acquired":false,"shares":884161,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the OTR Acquisition Corp.'s registration statement on Form S-1 (File No. 333-248093) under the heading \"Description of Securities,\" the Class B common stock, par value U.S. $0.0001 per share, of the issuer (the \"Founder Shares\") will automatically convert into Class A common stock of the issuer at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On May 6, 2022, OTR Acquisition Sponsor LLC (the \"Sponsor\") transferred an aggregate of 1,305,920 shares of Class B common stock, par value U.S. $0.0001 per share, of OTR Acquisition Corp. (\"Founder Shares\") and 5,817,757 warrants previously held by the Sponsor to certain members of the Sponsor, including 421,759 Founder Shares and 762,634 warrants to the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the OTR Acquisition Corp.'s registration statement on Form S-1 (File No. 333-248093) under the heading \"Description of Securities,\" the Class B common stock, par value U.S. $0.0001 per share, of the issuer (the \"Founder Shares\") will automatically convert into Class A common stock of the issuer at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the OTR Acquisition Corp.'s registration statement on Form S-1 (File No. 333-248093) under the heading \"Description of Securities,\" the Class B common stock, par value U.S. $0.0001 per share, of the issuer (the \"Founder Shares\") will automatically convert into Class A common stock of the issuer at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Includes (i) 421,759 Founder Shares held directly by the reporting person, (ii) 1,305,918 Founder Shares held directly by the reporting person. The reporting person is a managing member of the Sponsor. As such, the reporting person may be deemed to have beneficial ownership of such shares. The reporting person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":1727677,"derivative":{"underlying":"Class A Common Stock","underlying_shares":884161},"source":{"system":"sec-edgar","filing":"0001104659-22-057990","document":"tm2214998-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821318/000110465922057990/tm2214998-2_4seq1.xml","form_type":"4"}}]}